Watch Ticker

Crinetics Pharmaceuticals, Inc.

Go to Crinetics Pharmaceuticals, Inc. Website

$29.18

0.96 (3.40%)

Live

Previous Close

$28.22

Day Range

$27.65 - $29.925

Previous Day Range

$27.5975 - $28.39

Market Cap

$2.6 billion USD

Day Vol.

1.0 million

Previous Day Vol.

1.0 million

Currency

USD

Primary Exchange

Nasdaq

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Crinetics Pharmaceuticals - Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025

Crinetics Pharmaceuticals presented long-term clinical data on PALSONIFY, an oral medication for acromegaly, showing sustained IGF-1 level control and stable patient symptoms across two Phase 3 clinical trials.

Related tickers: CRNX.

Read Full Article

N/A - Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

Crinetics Pharmaceuticals announced that it will present new research on its investigational drugs paltusotine and atumelnant at the American Association of Clinical Endocrinology Annual Meeting 2025. The company also granted inducement grants to employees in May 2025.

Related tickers: CRNX.

Read Full Article

Trending Tickers

Please sign in to view